Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data OSR Health, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2022
FY2022
FY2023
FY2024
FY2025
Revenue
3.53
2.91
Cost of revenue
2.72
2.31
Gross profit
0.81
0.59
Research and development
0.16
0.32
Selling, general and administrative
0
0.04
1.83
12.5
18.9
Selling and marketing
0
General and administrative
1.83
3.52
Operating income
-0
-0.04
-1.83
-11.7
-18.3
Interest expense
0.05
0.51
Interest income
2.78
0.02
0.06
Other non-operating income
2.78
1.41
Pre-tax income
0.94
-11.9
-28.9
Income tax
0.54
-1.56
-1.83
Income from continuing operations
-0.04
-1.83
Net income to minority interests
-9.05
Net income
-0
-0.04
0.4
-2.41
-18
EBITDA
-11.7
-18.3
EPS, basic
0.00
-0.09
0.44
-4.79
-0.92
EPS, diluted
0.00
-0.09
0.44
-4.79
-0.80
Shares, basic (weighted)
0.17
0.17
0.87
2.16
19.5
Shares, diluted (weighted)
0.17
0.17
0.87
2.16
22.6
Balance sheet
FY2022
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0
0.12
0.02
0.34
1.7
Receivables
0.9
0.32
Inventory
0.92
0.2
Other current assets
0.01
0.07
0.26
Total current assets
0
0.12
0.02
2.33
2.82
Property, plant and equipment
0
0.17
Lease right-of-use assets
0.08
0.06
Goodwill
27.8
24.4
24.9
Intangible assets
148
142
Total assets
0.71
1.23
36.6
175
171
Accounts payable
0
0.03
1.08
2.88
Accrued liabilities
0.46
0.96
Short-term debt
1.14
2.02
1.8
2.32
Total current liabilities
0.71
1.26
2.04
3.46
17.2
Long-term debt
0.5
Lease liabilities
0.03
0.01
Other non-current liabilities
0
0
Total liabilities
0.71
1.26
4.11
32
44.2
Total debt
0.5
Paid-in capital
0.02
0.02
0
163
111
Retained earnings
-0.03
-0.06
-3.91
-19.2
-37.2
Other comprehensive income
-0.23
3.84
Shareholders' equity
-0
-0.04
-3.91
-8.33
Minority interests
0
49.4
Total equity
-0
-0.04
153
143
127
Total liabilities and equity
0.71
1.23
36.6
175
171
Shares outstanding
0.19
0.19
0.24
2.16
26.6
Cash flow statement
FY2022
FY2022
FY2023
FY2024
FY2025
Net income
-0
-0.04
0.4
-10.3
-27.1
Depreciation and amortization
0.01
0.01
Deferred income tax
0.34
0.74
Change in inventory
0.31
0.76
Change in payables
0
0.03
1.04
1.8
Cash from operations
-0
-0
-0.82
-1.85
-4.33
Acquisitions
1.22
Purchases of investments
-0.18
-0.48
Cash from investing
-33.8
0.5
-2.64
Debt issued
0.24
Stock issued
9.16
4.8
Share buybacks
-36
-36.2
Cash from financing
-0.06
0.12
34.5
1.18
8.37
Exchange rate effect
-0.04
-0.04
Net change in cash
-0.06
0.12
-0.11
-0.16
1.4
Interest paid
0.05
0.51
Income taxes paid
0.02
0.01
0.15
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.23 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
35.3%
Gross profit / revenue.
Operating margin
-933.7%
Operating income / revenue.
EBITDA margin
-932.4%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-974.9%
Pre-tax income / revenue.
Net margin
-593.2%
Net income / revenue.
Operating cash flow margin
-398.3%
Cash from operations / revenue.
Return on assets (ROA)
-6.4%
Net income / average total assets.
R&D / revenue
21.2%
Research and development expense / revenue.
SG&A / revenue
969.0%
Selling, general and administrative expense / revenue.
D&A / revenue
1.3%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-17.7%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
-26.9%
Gross profit vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-2.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
418.9%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
946.9%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
411.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.18x
Current assets / current liabilities.
Quick ratio
0.11x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.10x
(Cash + short-term investments) / current liabilities.
Debt / assets
0.3%
Total debt / total assets.
Liabilities / assets
25.0%
Total liabilities / total assets.
Net debt
-$955.6K
Total debt - cash - short-term investments. Negative means more cash than debt.
Market cap + total debt - cash - short-term investments.
P/S
4.37x
Market cap / revenue.
EV/Sales
3.84x
Enterprise value / revenue.
Earnings yield
-135.8%
Net income / market cap (the inverse of P/E).
What was OSR Health, Inc.'s revenue in fiscal 2025?
OSR Health, Inc. reported revenue of $2.9M for fiscal 2025, 17.7% lower than the year before.
Was OSR Health, Inc. profitable in fiscal 2025?
No. It reported a net loss of $18.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.